RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
The dopamine transporter (DAT), a protein located on presynaptic nerve terminals (4), plays a major role in the reuptake of released dopamine. Uptake of DA is sodium- and chloride Ion-, as well as temperature- and lime-dependent, and is inhibited by a variety of compounds, including cocaine. Even though cocaine binds to several sites in the brain, only binding potencies at the DA site have been shown to correlate with the reinforcing properties of cocaine in animal models, which are the primary factors in its abuse. Thus, the DAT has been called a cocaine receptor (21) and may be the initial site responsible for producing cocaine's drug reinforcement. The cDNA for the DAT has been cloned from rat (3), bovine (88), and human (92) brains. The hydrophobicity profile indicates 12 possible membrane-spanning regions with the ammo and carboxy termini located intracellularly. The protein from human and rat brains contains three and four extracellular N-glycosylation sites, respectively.